Update

Department of Transportation | HDOT COVID-19 update: Identification credentials, safety checks, and vehicle registrations

HDOT COVID-19 update: Identification credentials, safety checks, and vehicle registrations

Posted on Apr 30, 2020 in Highways News, Main, News

HONOLULU – In consideration of Governor Ige’s 6th supplementary emergency proclamation through May 31, 2020, the Hawaii Department of Transportation (HDOT) provides the following updates on identification credentials, Periodic Motor Vehicle Inspections (PMVI or Safety Checks), and motor vehicle registrations.

Identification Credentials (Driver’s Licenses, State Identification Cards)

  • Driver’s licenses, instruction permits, and State Identification cards that expire between March 15 and May 31, 2020, are granted a 90-day waiver. All State-issued credentials expiring during this date range will be considered valid for an additional 90-days from the end of Governor Ige’s 6th supplementary emergency proclamation on May 31, 2020. This extension is to provide enough time for the public to obtain or renew credentials once face-to-face government services are reopened.
  • Commercial Driver’s License (CDL) holders with a CDL that expired
Read More

Good News from the Industry as it Rallies Against the Spread of Covid-19 [Update: Muc-Off Launch Anti-Bac Fight Back Program]

Among the constant bad news about the worsening spread of the COVID-19 pandemic, brands and people in the bike industry are trying to make the most of a bad situation. Check out some of the positive news stories to come through our inbox.

Muc-Off launch ‘Anti Bac Fight Back’ project

Muc-Off has added to their recent efforts of assisting with the shortage of plastic bottles for hand sanitiser by launching their new ‘Anti Bac Fight Back’ project. The new program from the UK based company sees them take three different approaches to the situation. Support front line workers, protecting people and global support.

Adding to their previous efforts Muc-Off is now providing ITU nurses with anti-bacterial moisturising creams to help with the soreness creating by wearing face masks during their shifts. The aim is to donate 100,000 products to front line health workers.

They have also released a new range

Read More

Good News from the Industry as it Rallies Against the Spread of Covid-19 [Update: Santa Cruz Bicycles Produces Face Masks]

Among the constant bad news about the worsening spread of the COVID-19 pandemic, brands and people in the bike industry are trying to make the most of a bad situation. Check out some of the positive news stories to come through our inbox.

Santa Cruz Bicycles’ R&D Team Uses CNC Machinery to Produce Face Shields for Local Medical Staff

Although Santa Cruz, California is in a shelter-in-place like most of the world, Santa Cruz Bicycles’ R&D team is at work producing face shields (PPE) for local medical staff using sheets of plastic cut using their CNC machinery typically used for cutting carbon fiber as well as 3D printers used for prototyping.

The equipment is able to make up to 20 face shield lenses every 9 minutes, yielding ~1000 shields per day. Ten days were spent evaluating designs, developing multiple prototypes and getting feedback from local healthcare professionals to ensure the

Read More

Bicycle Therapeutics Announces Pipeline Progress Update

CAMBRIDGE, England & BOSTON–(BUSINESS WIRE)–Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced progress updates across its wholly-owned and partnered programs in oncology and non-oncology indications.

“We and our partners have recently achieved important progress in the advancement of our pipeline that we believe could catalyze the next stage of growth for Bicycle,” said Kevin Lee, Ph.D., Chief Executive Officer of Bicycle Therapeutics. “Cancer Research UK has identified a recommended dose, which is within the therapeutic range predicted by preclinical models, for the Phase IIa study of BT1718, which we expect to commence this year. Our next-generation Bicycle Toxin Conjugates (BTCs), BT5528 and BT8009, are quickly progressing through respective stages of development. In addition, we believe our recently announced early discovery collaboration with Genentech will allow us to make

Read More